Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsung-Hui Hu

Showing results (71-80 of 364) with videos related to

Pageof 37
Sort By:
Scientific Reports|May 14, 2017
Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mLChih-Chien Yao, Chao-Hung Hung, Tsung-Hui Hu, et al.
Antiviral Therapy|October 26, 2011
Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patientsChao-Hung Hung, Sheng-Nan Lu, Jing-Houng Wang, et al.
Plos One|January 10, 2019
Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis CYi-Hao Yen, Kwong-Ming Kee, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2016
Clinical Relapse After Cessation of Tenofovir Therapy in Hepatitis B e Antigen-Negative PatientsWen-Juei Jeng, Yi-Cheng Chen, I-Shyan Sheen, et al.
Viruses|June 24, 2022
Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical RelapseTzu-Ning Tseng, Yuan-Hung Kuo, Tsung-Hui Hu, et al.
Plos One|October 4, 2019
Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected dataYi-Hao Yen, Chien-Hung Chen, Chao-Hung Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 11, 2016
Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogsMing-Chao Tsai, Chien-Hung Chen, Tsung-Hui Hu, et al.
World Journal of Gastroenterology|July 1, 2014
Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analoguesChien-Hung Chen, Yi-Chun Chiu, Sheng-Nan Lu, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 8, 2026
Predictors of True Early Recurrence in Patients Undergoing Radiofrequency Ablation for Hepatocellular CarcinomaYi-Hao Yen, Kwong-Ming Kee, Chao-Hung Hung, et al.
Intervirology|February 15, 2013
Amino acid substitutions in the core region associate with insulin resistance in chronic hepatitis CChao-Hung Hung, Tsung-Hui Hu, Chuan-Mo Lee, et al.
Pageof 37

Showing results (71-80 of 364) with videos related to

Sort By:
Pageof 37
Scientific Reports|May 14, 2017
Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mLChih-Chien Yao, Chao-Hung Hung, Tsung-Hui Hu, et al.
Antiviral Therapy|October 26, 2011
Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patientsChao-Hung Hung, Sheng-Nan Lu, Jing-Houng Wang, et al.
Plos One|January 10, 2019
Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis CYi-Hao Yen, Kwong-Ming Kee, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2016
Clinical Relapse After Cessation of Tenofovir Therapy in Hepatitis B e Antigen-Negative PatientsWen-Juei Jeng, Yi-Cheng Chen, I-Shyan Sheen, et al.
Viruses|June 24, 2022
Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical RelapseTzu-Ning Tseng, Yuan-Hung Kuo, Tsung-Hui Hu, et al.
Plos One|October 4, 2019
Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected dataYi-Hao Yen, Chien-Hung Chen, Chao-Hung Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 11, 2016
Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogsMing-Chao Tsai, Chien-Hung Chen, Tsung-Hui Hu, et al.
World Journal of Gastroenterology|July 1, 2014
Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analoguesChien-Hung Chen, Yi-Chun Chiu, Sheng-Nan Lu, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 8, 2026
Predictors of True Early Recurrence in Patients Undergoing Radiofrequency Ablation for Hepatocellular CarcinomaYi-Hao Yen, Kwong-Ming Kee, Chao-Hung Hung, et al.
Intervirology|February 15, 2013
Amino acid substitutions in the core region associate with insulin resistance in chronic hepatitis CChao-Hung Hung, Tsung-Hui Hu, Chuan-Mo Lee, et al.
Pageof 37